Skip to main content
OpenTrials
Completed

NCT Number: NCT05460039

Impact of a Technology Mediated Dance Intervention

This study aims to investigate whether a technology-mediated dance impacts on psychosocial, physical and cognitive functions of the old adults when compared to usual activities.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Older Adults Without Any Specific Clinical Condition

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

School of Health Sciences

Aveiro, Portugal

About this study

This study aims to investigate whether a technology-mediated dance impacts on psychosocial, physical, and cognitive functions of old adults when compared to usual activities. It will have two arms one of which will receive a dance mat and perform dance sessions for 8 weeks, while the other group will continue their usual activities. Participants will be assessed for psychosocial, physical, and cognitive aspects at baseline, end of the intervention, and at 3 months follow-up.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • People living independently in the community
  • 65 years old or older
  • With no cognitive impairment defined based on the 6-item cognitive decline test [4]
  • Independent at walking without walking aids
  • Access to a personal computer and internet
  • For older adults unable to use a computer, a patient or carer with digital literacy needs to be identified for the older adult to enter the study.

Exclusion criteria

  • Reporting cardiovascular pathology that limits the performance of the dance or dizziness or imbalance prior to using the mat

Treatment and study plan

Dance mediated by tecnhology

Other

A web system and a dance mat are used to stimulate participants to perform dance activities for 8 weeks.

Primary outcomes

  1. Gait velocity

    Time frame: Baseline

    Assessed using the gait velocity test, i.e., the velocity of gait when walking in a straight line for 4 meters; it is measured in meters per second.

  2. Gait velocity

    Time frame: After the intervention (8 weeks after baseline assessment)

    Assessed using the gait velocity test, i.e., the velocity of gait when walking in a straight line for 4 meters; it is measured in meters per second.

  3. Gait velocity

    Time frame: At 3 months follow up

    Assessed using the gait velocity test, i.e., the velocity of gait when walking in a straight line for 4 meters; it is measured in meters per second.

Secondary outcomes

  1. Balance

    Time frame: Baseline

    Balance will be assessed through the Functional Reach Test, which measures the ability of a person to reach forward without moving the feet; it is measured in cm.

  2. Balance

    Time frame: After the intervention (8 weeks after baseline assessment)

    Balance will be assessed through the Functional Reach Test, which measures the ability of a person to reach forward without moving the feet; it is measured in cm.

  3. Balance

    Time frame: At 3 months follow up

    Balance will be assessed through the Functional Reach Test, which measures the ability of a person to reach forward without moving the feet; it is measured in cm.

  4. Cognitive functioning

    Time frame: Baseline

    This will be measured using the Trail Making Test which is a paper-based test; score is given in seconds.

  5. Cognitive functioning

    Time frame: After the intervention (8 weeks after baseline assessment)

    This will be measured using the Trail Making Test which is a paper-based test; score is given in seconds.

  6. Cognitive functioning

    Time frame: At 3 months follow up

    This will be measured using the Trail Making Test which is a paper-based test; score is given in seconds.

  7. Pain intensity

    Time frame: Baseline

    Measured with a 100 mm Vertical Numeric Pain Rating Scale, anchored with 0 (no pain) and 100 (worst possible pain)

  8. Pain intensity

    Time frame: After the intervention (8 weeks after baseline assessment)

    Measured with a 100 mm Vertical Numeric Pain Rating Scale, anchored with 0 (no pain) and 100 (worst possible pain)

  9. Pain intensity

    Time frame: At 3 months follow up

    Measured with a 100 mm Vertical Numeric Pain Rating Scale, anchored with 0 (no pain) and 100 (worst possible pain)

  10. Quality of life

    Time frame: Baseline

    Measured using the WHOQOL-Bref (WHO Quality of Life questionnaire); scores range between 0 to 20 and higher scores indicate better quality of life

  11. Quality of life

    Time frame: After the intervention (8 weeks after baseline assessment)

    Measured using the WHOQOL-Bref (WHO Quality of Life questionnaire); scores range between 0 to 20 and higher scores indicate better quality of life

  12. Quality of life

    Time frame: At 3 months follow up

    Measured using the WHOQOL-Bref (WHO Quality of Life questionnaire); scores range between 0 to 20 and higher scores indicate better quality of life

  13. Health status

    Time frame: Baseline

    Measured using the EuroQoL EQ-5D; scores range from 5 to 25 and higher scores; indicate lower quality of life (note: according to the EuroQol Research Foundation, EQ-5D is not an abbreviation and is the correct term to use in print or verbally)

  14. Health status

    Time frame: After the intervention (8 weeks after baseline assessment)

    Measured using the EuroQoL EQ-5D; scores range from 5 to 25 and higher scores; indicate lower quality of life (note: according to the EuroQol Research Foundation, EQ-5D is not an abbreviation and is the correct term to use in print or verbally)

  15. Health status

    Time frame: At 3 months follow up

    Measured using the EuroQoL EQ-5D; scores range from 5 to 25 and higher scores; indicate lower quality of life (note: according to the EuroQol Research Foundation, EQ-5D is not an abbreviation and is the correct term to use in print or verbally)

  16. Self-efficacy

    Time frame: Baseline

    Measured using the Perceived Self-Efficacy Scale; scores vary between 10 and 40 and higher scores indicate higher self-efficacy

  17. Self-efficacy

    Time frame: After the intervention (8 weeks after baseline assessment)

    Measured using the Perceived Self-Efficacy Scale; scores vary between 10 and 40 and higher scores indicate higher self-efficacy

  18. Self-efficacy

    Time frame: At 3 months follow up

    Measured using the Perceived Self-Efficacy Scale; scores vary between 10 and 40 and higher scores indicate higher self-efficacy

  19. Loneliness

    Time frame: Baseline

    Measured using the University of California, Los Angeles, Loneliness Scale; scores vary between 4 and 28 and higher scores indicate higher loneliness

  20. Loneliness

    Time frame: After the intervention (8 weeks after baseline assessment)

    Measured using the University of California, Los Angeles, Loneliness Scale; scores vary between 4 and 28 and higher scores indicate higher loneliness

  21. Loneliness

    Time frame: At 3 months follow up

    Measured using the University of California, Los Angeles, Loneliness Scale; scores vary between 4 and 28 and higher scores indicate higher loneliness

  22. Social support

    Time frame: Baseline

    Measured with the Oslo Social Support Scale (OSSS-3) with Life Events Scale; score varies between 3 and 14 and higher scores indicate stronger social support

  23. Social support

    Time frame: After the intervention (8 weeks after baseline assessment)

    Measured with the Oslo Social Support Scale (OSSS-3) with Life Events Scale; score varies between 3 and 14 and higher scores indicate stronger social support

  24. Social support

    Time frame: At 3 months follow up

    Measured with the Oslo Social Support Scale (OSSS-3) with Life Events Scale; score varies between 3 and 14 and higher scores indicate stronger social support

Sponsors and collaborators

Lead sponsor

Aveiro University

Other

Registry information

Official study title

Technology-mediated Dance: Impact on Psychossocial, Physical, and Cognitive Functions of the Old

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jul 15, 2022
Registry last updated
Feb 6, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.